文献速递传染病防控与疫情报告卫生政策与健康促进

微小扇头蜱三种候选抗原的计算机筛选与兔体抗蜱疫苗评价

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.
PubMed 文献 · Vaccine · 2026-06-30

研究通过理化分析、免疫学与表位预测从微小扇头蜱中筛选出Rm-SSD、Rm-IMP和Rm-Nep三种蛋白,在大肠杆菌表达纯化后以油佐剂免疫新西兰白兔(每组4只),再以林奈扇头蜱成虫和若虫实验感染。三种疫苗总体效力分别为47.47%、58.72%和64.20%,支持其作为未来牛用 cocktail 疫苗的候选。

要点

  • Rm-Nep组若虫数降39.22%、幼虫孵化降41.11%,总体效力64.20%。
  • Rm-IMP组雌成虫数降22.95%、产卵降10.82%、孵化降39.91%,效力58.72%。
  • Rm-SSD组雌成虫产卵降15.96%、卵育性降37.45%,总体效力47.47%。

核心结论

  • 三种重组蛋白均显示抗蜱潜力,其中Rm-Nep总体疫苗效力最高(64.20%)。
  • 结果支持这些蛋白未来作为 cocktail 疫苗用于野外放牧牛群控制微小扇头蜱。

研究设计与样本

  • 基于理化分析、免疫学与表位预测从微小扇头蜱中筛选三种候选蛋白。
  • 重组蛋白经大肠杆菌表达和色谱纯化,以油佐剂乳化免疫新西兰白兔。
  • 兔分四组(每组n=4):PBS对照及Rm-SSD、Rm-IMP、Rm-Nep三个实验组。
  • 免疫后以林奈扇头蜱成虫和若虫实验感染兔。

主要发现

  • Rm-SSD使雌成虫产卵最高降15.96%、卵育性降37.45%,总体效力47.47%。
  • Rm-IMP使雌成虫数最高降22.95%、产卵降10.82%、幼虫孵化降39.91%,总体效力58.72%。
  • Rm-Nep使若虫数降39.22%、幼虫孵化最高降41.11%,总体效力64.20%。

临床怎么用

  • 三种蛋白可作为抗微小扇头蜱候选疫苗抗原,优先关注效力最高的Rm-Nep。
  • 未来可探索 cocktail 疫苗策略用于野外放牧牛群的蜱防控。

局限性

  • 研究仅在兔模型中进行,样本量小(每组n=4),尚未在牛体验证。
  • 攻毒使用林奈扇头蜱模型,非直接针对微小扇头蜱现场感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ticks are parasitic arthropods, responsible for vectoring tick-borne pathogens to animals and humans. Globally, synthetic acaricides are used to control tick infestations; however, alternative controls methods are in development. In this study, Rhipicephalus microplus (Rm)-scoloptoxin SSD14 (Rm-SSD), Rm-inositol monophosphatase (Rm-IMP), and Rm-neprilysin (Rm-Nep) proteins were characterized as anti-tick vaccine candidates. Based on physicochemical analyses, immunological and epitope prediction these three Rhipicephalus microplus proteins were selected as vaccine candidates against Rhipicephalus linnaei tick model infestation. The recombinant proteins were expressed in Escherichia coli system followed by purification using chromatography. The vaccination challenge was conducted using New Zeeland white rabbits divided into four groups (n = 4 per group): a PBS control group and three experimental groups immunized with the Rm-SSD, Rm-IMP or Rm-Nep emulsified in oil-based adjuvant. After immunization, rabbits were experimentally infested with adult and nymphal stages of R. linnaei. Following vaccination, Rm-SSD significantly reduced adult female egg laying by up to 15.96% and egg fertility by 37.45%, resulting in an overall vaccine efficacy of 47.47%. Rm-IMP significantly reduced the number of adult females by up to 22.95%, egg laying by up to 10.82%, and larval hatching by 39.91%, accounting for a total vaccine efficacy of 58.72%. Rm-Nep significantly reduced nymph numbers by 39.22% and larval hatching by up to 41.11%, with an overall vaccine efficacy of 64.20%.The results of the current study justify the use of these proteins in future as cocktail vaccine against R. microplus infesting field grazing bovines. Such strategy contributes to offering a more robust and sustainable approach for tick control under diverse climatic conditions.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ullah S, Parizi LF, Almutairi MM, et al. In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines. Vaccine. 2026. PMID: 42378924. doi:10.1016/j.vaccine.2026.128789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。